Page last updated: 2024-08-24

gemcitabine and Cutaneous T-Cell Lymphoma

gemcitabine has been researched along with Cutaneous T-Cell Lymphoma in 19 studies

Research

Studies (19)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's9 (47.37)29.6817
2010's8 (42.11)24.3611
2020's2 (10.53)2.80

Authors

AuthorsStudies
Assaf, C; Blazejak, C; Gambichler, T; Gosman, J; Klemke, CD; Nicolay, JP; Olk, J; Stadler, R; Stendel, S; Stranzenbach, R; Wehkamp, U; Weyermann, M; Wobser, M1
Bianchi, L; Cantonetti, M; Di Raimondo, C; Meconi, F; Monopoli, A; Narducci, MG; Nunzi, A; Rapisarda, V; Scala, E; Tesei, C; Vaccarini, S; Zizzari, A1
Cronin, M; Fox, JD; Gonzalez, AM; Kirsner, RS; Mackrides, N; Nichols, AJ; Zito, PM1
Chan, C; Counsell, N; Cowan, R; Gilson, D; Illidge, T; Morris, S; Patrick, P; Popova, B; Scarisbrick, J; Smith, P; Whittaker, S1
Argnani, L; Casadei, B; Maglie, R; Pellegrini, C; Stefoni, V; Zinzani, PL1
Affandi, AM; Blumetti, TP; Fernandez-PeƱas, P; Hertzberg, M; Wells, J1
Amoh, Y; Masuzawa, M; Takasu, H1
Chen, CC; Teng, CL; Yeh, SP1
Bachelez, H; Beylot-Barry, M; Chaoui, D; Dubertret, L; Ingen-Housz-Oro, S; Jidar, K; Morel, P; Paul, C; Sigal-Grinberg, M1
Balaraman, B; Conley, JA; Sheinbein, DM1
Battistella, M; Sassolas, B1
Bianchi, L; Cantonetti, M; Chimenti, S; Fargnoli, MC; Muscardin, LM; Orlandi, A; Pagnanelli, G1
Dumontet, C1
Besalduch, J; Galmes, B; Gines, J; Gutierrez, A; Ramos, R; Rodriguez, J; Sampol, A1
Alinari, L; Baccarani, M; Bernengo, MG; Berti, E; Marchi, E; Pagano, L; Pileri, S; Pimpinelli, N; Rupoli, S; Stefoni, V; Tani, M; Zaja, F; Zinzani, PL1
Apisarnthanarax, N; David, CL; Duvic, M; Kurzrock, R; Talpur, R; Wen, S1
Ascani, S; Baliva, G; Bendandi, M; Gherlinzoni, F; Magagnoli, M; Modugno, G; Orcioni, GF; Pileri, SA; Simoni, R; Tura, S; Zinzani, PL1
Nguyen, NP; Sallah, S; Wan, JY1
Gandhi, V; Krett, N; Nabhan, C; Rosen, S1

Reviews

5 review(s) available for gemcitabine and Cutaneous T-Cell Lymphoma

ArticleYear
[Gemcitabine Monotherapy for Advanced Mycosis Fungoides--Two Case Reports and a Literature Review].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2015, Volume: 42, Issue:13

    Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Deoxycytidine; Doxorubicin; Drug Resistance, Neoplasm; Fatal Outcome; Female; Gemcitabine; Humans; Lymphoma, T-Cell, Cutaneous; Male; Mycosis Fungoides; Prednisone; Skin Neoplasms; Vincristine

2015
Relapsed and refractory subcutaneous panniculitis-like T-cell lymphoma with excellent response to cyclosporine: a case report and literature review.
    Annals of hematology, 2016, Volume: 95, Issue:5

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclosporine; Cytarabine; Deoxycytidine; Dexamethasone; Drug Resistance, Neoplasm; Etoposide; Gemcitabine; Humans; Immunosuppressive Agents; Lymphoma, T-Cell, Cutaneous; Male; Methylprednisolone; Multimodal Imaging; Panniculitis; Positron-Emission Tomography; Recurrence; Remission Induction; Salvage Therapy; Skin Neoplasms; Subcutaneous Fat; Tomography, X-Ray Computed

2016
Evaluation of cutaneous angioimmunoblastic T-cell lymphoma.
    Journal of the American Academy of Dermatology, 2011, Volume: 65, Issue:4

    Topics: Aged; Arthralgia; Cyclophosphamide; Deoxycytidine; Diphtheria Toxin; Doxorubicin; Epstein-Barr Virus Infections; Gemcitabine; Gene Rearrangement, T-Lymphocyte; Humans; Immunoblastic Lymphadenopathy; Interleukin-2; Lymphoma, T-Cell, Cutaneous; Male; Methotrexate; Prednisolone; Pruritus; Recombinant Fusion Proteins; Retrospective Studies; Skin Neoplasms; Stem Cell Transplantation; Vinblastine; Vincristine; Vinorelbine

2011
[The role of gemcitabine in hematology].
    Bulletin du cancer, 2002, Volume: 89 Spec No

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Deoxycytidine; DNA Damage; DNA, Neoplasm; Drug Design; Gemcitabine; Hematologic Neoplasms; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Cutaneous; Multiple Myeloma; Neoplasm Proteins; Nucleotides; Ribonucleotide Reductases; Salvage Therapy; Treatment Outcome

2002
Gemcitabine in hematologic malignancies.
    Current opinion in oncology, 2001, Volume: 13, Issue:6

    Topics: Antimetabolites, Antineoplastic; Clinical Trials as Topic; Deoxycytidine; DNA; Gemcitabine; Hodgkin Disease; Humans; Leukemia; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Cutaneous; Tumor Cells, Cultured

2001

Trials

5 trial(s) available for gemcitabine and Cutaneous T-Cell Lymphoma

ArticleYear
Phase II study of gemcitabine and bexarotene (GEMBEX) in the treatment of cutaneous T-cell lymphoma.
    British journal of cancer, 2013, Nov-12, Volume: 109, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bexarotene; Deoxycytidine; Feasibility Studies; Female; Gemcitabine; Humans; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Remission Induction; Skin Neoplasms; Tetrahydronaphthalenes; Treatment Outcome; United Kingdom

2013
Gemcitabine as frontline treatment for cutaneous T-cell lymphoma: phase II study of 32 patients.
    Cancer, 2005, Dec-01, Volume: 104, Issue:11

    Topics: Adult; Aged; Antimetabolites, Antineoplastic; Deoxycytidine; Female; Gemcitabine; Humans; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Neoplasm Staging; Survival Analysis; Treatment Outcome

2005
Phase II evaluation of gemcitabine monotherapy for cutaneous T-cell lymphoma.
    Clinical lymphoma & myeloma, 2006, Volume: 7, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Deoxycytidine; Female; Gemcitabine; Humans; Infusions, Intravenous; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Mycosis Fungoides; Receptors, Interleukin-2; Sezary Syndrome; Skin Neoplasms; Treatment Outcome

2006
Gemcitabine treatment in pretreated cutaneous T-cell lymphoma: experience in 44 patients.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:13

    Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Deoxycytidine; Female; Gemcitabine; Humans; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Mycosis Fungoides; Skin Neoplasms; Survival Rate

2000
Treatment of refractory T-cell malignancies using gemcitabine.
    British journal of haematology, 2001, Volume: 113, Issue:1

    Topics: Aged; Antimetabolites, Antineoplastic; Deoxycytidine; Drug Administration Schedule; Female; Gemcitabine; Humans; Infusions, Intravenous; Leukemia, Prolymphocytic; Lymphoma, T-Cell; Lymphoma, T-Cell, Cutaneous; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Recurrence; Salvage Therapy; Treatment Outcome

2001

Other Studies

9 other study(ies) available for gemcitabine and Cutaneous T-Cell Lymphoma

ArticleYear
Clinical Outcomes of Advanced-Stage Cutaneous Lymphoma under Low-Dose Gemcitabine Treatment: Real-Life Data from the German Cutaneous Lymphoma Network.
    Dermatology (Basel, Switzerland), 2022, Volume: 238, Issue:3

    Topics: Breast Neoplasms; Deoxycytidine; Female; Gemcitabine; Humans; Lymphoma, T-Cell, Cutaneous; Mycosis Fungoides; Retrospective Studies; Skin Neoplasms; Treatment Outcome

2022
Continuous low-dose gemcitabine in primary cutaneous T cell lymphoma: A retrospective study.
    Dermatologic therapy, 2022, Volume: 35, Issue:6

    Topics: Deoxycytidine; Gemcitabine; Humans; Lymphoma, T-Cell, Cutaneous; Mycosis Fungoides; Retrospective Studies; Sezary Syndrome; Skin Neoplasms

2022
Widespread Skin Necrosis Secondary to Gemcitabine Therapy.
    Journal of drugs in dermatology : JDD, 2018, May-01, Volume: 17, Issue:5

    Topics: Antimetabolites, Antineoplastic; Deoxycytidine; Diagnosis, Differential; Female; Gemcitabine; Humans; Lymphoma, T-Cell, Cutaneous; Middle Aged; Skin Neoplasms; Stevens-Johnson Syndrome

2018
Long-term outcome of patients with advanced-stage cutaneous T cell lymphoma treated with gemcitabine.
    Annals of hematology, 2014, Volume: 93, Issue:11

    Topics: Adult; Aged; Antimetabolites, Antineoplastic; Deoxycytidine; Disease-Free Survival; Drug Administration Schedule; Female; Follow-Up Studies; Gemcitabine; Humans; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Retrospective Studies; Skin Neoplasms; Time Factors; Treatment Outcome

2014
Gemcitabine and vinorelbine treatment in cutaneous T-cell lymphoma in four patients.
    The Australasian journal of dermatology, 2015, Volume: 56, Issue:4

    Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Female; Gemcitabine; Humans; Lymphoma, T-Cell, Cutaneous; Male; Retreatment; Skin Neoplasms; Treatment Outcome; Vinblastine; Vinorelbine

2015
Gemcitabine treatment in cutaneous T-cell lymphoma: a multicentre study of 23 cases.
    The British journal of dermatology, 2009, Volume: 161, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Retrospective Studies; Skin Neoplasms; Vinblastine; Vinorelbine

2009
[Therapeutic perspectives of cutaneous T-cell lymphoma].
    Annales de dermatologie et de venereologie, 2011, Volume: 138, Issue:5 Suppl 2

    Topics: Antineoplastic Agents; Bexarotene; Clinical Trials as Topic; Deoxycytidine; Gemcitabine; Histone Deacetylase Inhibitors; Humans; Interferons; Lymphoma, T-Cell, Cutaneous; Retinoids; Skin Neoplasms; Tetrahydronaphthalenes

2011
Disseminated pagetoid reticulosis presenting as cytotoxic CD4/CD8 double negative cutaneous T-cell lymphoma.
    Acta dermato-venereologica, 2002, Volume: 82, Issue:4

    Topics: Adult; Antimetabolites, Antineoplastic; CD4 Antigens; CD8 Antigens; Deoxycytidine; Gemcitabine; Humans; Lymphatic Diseases; Lymphoma, T-Cell, Cutaneous; Male; Skin Neoplasms

2002
Treatment with alemtuzumab in a case of refractory primary cutaneous CD30-negative CD8-positive cytotoxic large T-cell lymphoma.
    European journal of haematology, 2004, Volume: 72, Issue:5

    Topics: Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; CD8 Antigens; Cyclophosphamide; Deoxycytidine; Doxorubicin; Female; Gemcitabine; Humans; Immunophenotyping; Lymphoma, T-Cell, Cutaneous; Organoplatinum Compounds; Oxaliplatin; Pentostatin; Prednisone; Remission Induction; Salvage Therapy; Skin Neoplasms; Vincristine

2004